{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:31:27Z","timestamp":1785371487408,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13346-020-00894-2","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T05:49:26Z","timestamp":1610430566000},"page":"2252-2269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Thiolated polymer nanocarrier reinforced with glycyrrhetinic acid for targeted delivery of 5-fluorouracil in hepatocellular carcinoma"],"prefix":"10.1007","volume":"11","author":[{"given":"Sachin S.","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-5733","authenticated-orcid":false,"given":"Dhrubojyoti","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinal","family":"Sukharamwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachita","family":"Dehuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banala Venkatesh","family":"Teja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"issue":"9","key":"894_CR1","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.biomaterials.2013.12.045","volume":"35","author":"X Ma","year":"2014","unstructured":"Ma X, Cheng Z, Jin Y, Liang X, Yang X, Dai Z, et al. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy. Biomaterials. 2014;35(9):2878\u201389. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.12.045.","journal-title":"Biomaterials"},{"issue":"2","key":"894_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","volume":"30","author":"Z Xu","year":"2009","unstructured":"Xu Z, Chen L, Gu W, Gao Y, Lin L, Zhang Z, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 2009;30(2):226\u201332. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.09.014.","journal-title":"Biomaterials"},{"issue":"17","key":"894_CR3","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1016\/j.biomaterials.2010.02.042","volume":"31","author":"Q Tian","year":"2010","unstructured":"Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, et al. Glycyrrhetinic acid-modified chitosan\/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials. 2010;31(17):4748\u201356. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.02.042.","journal-title":"Biomaterials"},{"key":"894_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ijbiomac.2019.02.060","volume":"130","author":"R Shanmuganathan","year":"2019","unstructured":"Shanmuganathan R, Edison TNJI, LewisOscar F, Kumar P, Shanmugam S, Pugazhendhi A. Chitosan nanopolymers: an overview of drug delivery against cancer. Int J Biol Macromol. 2019;130:727\u201336. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.02.060.","journal-title":"Int J Biol Macromol"},{"key":"894_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcis.2014.12.053","volume":"445","author":"X She","year":"2015","unstructured":"She X, Chen L, Velleman L, Li C, Zhu H, He C, et al. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery. J Colloid Interface Sci. 2015;445:151\u201360. https:\/\/doi.org\/10.1016\/j.jcis.2014.12.053.","journal-title":"J Colloid Interface Sci"},{"key":"894_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.addr.2019.04.007","volume":"151\u2013152","author":"C Leichner","year":"2019","unstructured":"Leichner C, Jelkmann M, Bernkop-Schn\u00fcrch A. Thiolated polymers: bioinspired polymers utilizing one of the most important bridging structures in nature. Adv Drug Deliv Rev. 2019;151\u2013152:191\u2013221. https:\/\/doi.org\/10.1016\/j.addr.2019.04.007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"894_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1166\/jbn.2018.2638","volume":"14","author":"F Wu","year":"2018","unstructured":"Wu F, Li X, Jiang B, Yan J, Zhang Z, Qin J, et al. Glycyrrhetinic acid functionalized nanoparticles for drug delivery to liver cancer. J Biomed Nanotechnol. 2018;14(11):1837\u201352. https:\/\/doi.org\/10.1166\/jbn.2018.2638.","journal-title":"J Biomed Nanotechnol"},{"key":"894_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.carbpol.2018.04.052","volume":"195","author":"X Wang","year":"2018","unstructured":"Wang X, Gu X, Wang H, Yang J, Mao S. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid. Carbohyd Polym. 2018;195:170\u20139. https:\/\/doi.org\/10.1016\/j.carbpol.2018.04.052.","journal-title":"Carbohyd Polym"},{"key":"894_CR9","doi-asserted-by":"publisher","unstructured":"Zhang X, Ng HLH, Lu A, Lin C, Zhou L, Lin G, et al. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future. Nanomed Nanotechnol Biol Med. 2016;12(4):853\u201369. https:\/\/doi.org\/10.1016\/j.nano.2015.12.381.","DOI":"10.1016\/j.nano.2015.12.381"},{"issue":"1","key":"894_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0378-5173(03)00076-0","volume":"256","author":"CE Kast","year":"2003","unstructured":"Kast CE, Frick W, Losert U, Bernkop-Schn\u00fcrch A. Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering? Int J Pharm. 2003;256(1):183\u20139. https:\/\/doi.org\/10.1016\/S0378-5173(03)00076-0.","journal-title":"Int J Pharm"},{"issue":"11","key":"894_CR11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1080\/03639045.2018.1503297","volume":"44","author":"D Mukherjee","year":"2018","unstructured":"Mukherjee D, Srinivasan B, Anbu J, Azamthulla M, Banala VT, Ramachandra SG. Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film. Drug Dev Ind Pharm. 2018;44(11):1845\u201356. https:\/\/doi.org\/10.1080\/03639045.2018.1503297.","journal-title":"Drug Dev Ind Pharm"},{"key":"894_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejps.2014.07.002","volume":"63","author":"S Hauptstein","year":"2014","unstructured":"Hauptstein S, Bonengel S, Rohrer J, Bernkop-Schn\u00fcrch A. Preactivated thiolated poly(methacrylic acid-co-ethyl acrylate): synthesis and evaluation of mucoadhesive potential. Eur J Pharm Sci. 2014;63:132\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2014.07.002.","journal-title":"Eur J Pharm Sci"},{"key":"894_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jddst.2019.06.001","volume":"52","author":"D Mukherjee","year":"2019","unstructured":"Mukherjee D, Srinivasan B, Anbu J, Azamthulla M, Teja BV, Ramachandra SG, et al. Pamidronate functionalized mucoadhesive compact for treatment of osteoporosis-in vitro and in vivo characterization. J Drug Deliv Sci Technol. 2019;52:915\u201326. https:\/\/doi.org\/10.1016\/j.jddst.2019.06.001.","journal-title":"J Drug Deliv Sci Technol"},{"key":"894_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ijbiomac.2018.02.016","volume":"113","author":"B Xu","year":"2018","unstructured":"Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L. Eudragit L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. Int J Biol Macromol. 2018;113:534\u201342. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.02.016.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"894_CR15","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1208\/s12249-018-0972-9","volume":"19","author":"KC Petkar","year":"2018","unstructured":"Petkar KC, Chavhan S, Kunda N, Saleem I, Somavarapu S, Taylor KMG, et al. Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design. AAPS PharmSciTech. 2018;19(4):1758\u201372. https:\/\/doi.org\/10.1208\/s12249-018-0972-9.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"894_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijpharm.2012.10.030","volume":"441","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yao J, Zhou J, Wang T, Zhang Q. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm. 2013;441(1):654\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.10.030.","journal-title":"Int J Pharm"},{"key":"894_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cap.2020.03.002","author":"AA Alghyamah","year":"2020","unstructured":"Alghyamah AA, Haider S, Khalil U, Khan R, Haider A, Almasry WA, et al. Synthesis and characterization of graphene oxide, reduced graphene oxide and their nanocomposites with polyethylene oxide. Curr Appl Phys. 2020. https:\/\/doi.org\/10.1016\/j.cap.2020.03.002.","journal-title":"Curr Appl Phys"},{"key":"894_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.matchemphys.2018.07.039","volume":"218","author":"CDF Moreira","year":"2018","unstructured":"Moreira CDF, Carvalho SM, Sousa RG, Mansur HS, Pereira MM. Nanostructured chitosan\/gelatin\/bioactive glass in situ forming hydrogel composites as a potential injectable matrix for bone tissue engineering. Mater Chem Phys. 2018;218:304\u201316. https:\/\/doi.org\/10.1016\/j.matchemphys.2018.07.039.","journal-title":"Mater Chem Phys"},{"issue":"4","key":"894_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/02652048.2019.1631401","volume":"36","author":"S Santhosh","year":"2019","unstructured":"Santhosh S, Mukherjee D, Anbu J, Murahari M, Teja BV. Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. J Microencapsul. 2019;36(4):338\u201355. https:\/\/doi.org\/10.1080\/02652048.2019.1631401.","journal-title":"J Microencapsul"},{"key":"894_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00781-w","author":"J Park","year":"2020","unstructured":"Park J, Kim Y-C. Topical delivery of 5-fluorouracil-loaded carboxymethyl chitosan nanoparticles using microneedles for keloid treatment. Drug Deliv Transl Res. 2020. https:\/\/doi.org\/10.1007\/s13346-020-00781-w.","journal-title":"Drug Deliv Transl Res"},{"key":"894_CR21","doi-asserted-by":"publisher","unstructured":"Ahmadian E, Dizaj SM, Rahimpour E, Hasanzadeh A, Eftekhari A, Hosain zadegan H, et al. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line. Mater Sci Eng\u00a0C. 2018;93:465\u201371. https:\/\/doi.org\/10.1016\/j.msec.2018.08.027.","DOI":"10.1016\/j.msec.2018.08.027"},{"key":"894_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cbi.2017.07.008","volume":"274","author":"RR Radwan","year":"2017","unstructured":"Radwan RR, Zaher NH, El-Gazzar MG. Novel 1,2,4-triazole derivatives as antitumor agents against hepatocellular carcinoma. Chem Biol Interact. 2017;274:68\u201379. https:\/\/doi.org\/10.1016\/j.cbi.2017.07.008.","journal-title":"Chem Biol Interact"},{"issue":"8","key":"894_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/s1995-7645(12)60128-x","volume":"5","author":"T Hussain","year":"2012","unstructured":"Hussain T, Siddiqui HH, Fareed S, Vijayakumar M, Rao CV. Evaluation of chemopreventive effect of Fumaria indica against N-nitrosodiethylamine and CCl4-induced hepatocellular carcinoma in Wistar rats. AsianPac J Trop Med. 2012;5(8):623\u20139. https:\/\/doi.org\/10.1016\/s1995-7645(12)60128-x.","journal-title":"AsianPac J Trop Med"},{"key":"894_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00792-7","author":"RR Radwan","year":"2020","unstructured":"Radwan RR, Ali HE. Radiation-synthesis of chitosan\/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma. Drug Deliv Transl Res. 2020. https:\/\/doi.org\/10.1007\/s13346-020-00792-7.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"894_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jchromb.2004.01.043","volume":"804","author":"IA Alsarra","year":"2004","unstructured":"Alsarra IA, Alarifi MN. Validated liquid chromatographic determination of 5-fluorouracil in human plasma. J Chromatogr B. 2004;804(2):435\u20139. https:\/\/doi.org\/10.1016\/j.jchromb.2004.01.043.","journal-title":"J Chromatogr B"},{"key":"894_CR26","doi-asserted-by":"publisher","unstructured":"Ganguly K, Kulkarni AR, Aminabhavi TM. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-crosslinked chitosan microspheres in colorectal cancer therapy in rats. Drug Delivery. 2015:1\u201314.\u00a0https:\/\/doi.org\/10.3109\/10717544.2015.1089955.","DOI":"10.3109\/10717544.2015.1089955"},{"issue":"6","key":"894_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1248\/yakushi.130.801","volume":"130","author":"C Yan","year":"2010","unstructured":"Yan C, Gu J, Guo Y, Chen D. In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles. Yakugaku Zasshi. 2010;130(6):801\u20134.","journal-title":"Yakugaku Zasshi"},{"key":"894_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiec.2018.01.001","author":"V Sekar","year":"2018","unstructured":"Sekar V, Rajendran K, Vallinayagam S, Deepak V, Mahadevan S. Synthesis and characterization of chitosan ascorbate nanoparticles for therapeutic inhibition for cervical cancer and their in silico modeling. J Ind Eng Chem. 2018. https:\/\/doi.org\/10.1016\/j.jiec.2018.01.001.","journal-title":"J Ind Eng Chem"},{"issue":"1","key":"894_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijpharm.2016.05.007","volume":"510","author":"J Yin","year":"2016","unstructured":"Yin J, Xiang C, Song X. Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability. Int J Pharm. 2016;510(1):203\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.05.007.","journal-title":"Int J Pharm"},{"key":"894_CR30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.0c00663","author":"C Federer","year":"2020","unstructured":"Federer C, Kurpiers M, Bernkop-Schn\u00fcrch A. Thiolated chitosans: a multi-talented class of polymers for various applications. Biomacromol. 2020. https:\/\/doi.org\/10.1021\/acs.biomac.0c00663.","journal-title":"Biomacromol"},{"issue":"1","key":"894_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijpharm.2012.06.054","volume":"436","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wu X, Meng L, Zhang Y, Ai R, Qi N, et al. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm. 2012;436(1):341\u201350. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.054.","journal-title":"Int J Pharm"},{"key":"894_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.carbpol.2017.01.065","volume":"163","author":"MK G\u00f6k","year":"2017","unstructured":"G\u00f6k MK, Demir K, Cevher E, \u00d6zsoy Y, Cirit \u00dc, Bac\u0131no\u011flu S, et al. The effects of the thiolation with thioglycolic acid and l-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid). Carbohyd Polym. 2017;163:129\u201336. https:\/\/doi.org\/10.1016\/j.carbpol.2017.01.065.","journal-title":"Carbohyd Polym"},{"key":"894_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.commatsci.2014.01.042","volume":"86","author":"DJ Meena","year":"2014","unstructured":"Meena DJ. Aggregation of thiol coated gold nanoparticles: a simulation study on the effect of polymer coverage density and solvent. Comput Mater Sci. 2014;86:174\u20139. https:\/\/doi.org\/10.1016\/j.commatsci.2014.01.042.","journal-title":"Comput Mater Sci"},{"key":"894_CR34","doi-asserted-by":"publisher","first-page":"313961","DOI":"10.1155\/2012\/313961","volume":"2012","author":"RS T\u0131\u011fl\u0131 Ayd\u0131n","year":"2012","unstructured":"T\u0131\u011fl\u0131 Ayd\u0131n RS, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:313961. https:\/\/doi.org\/10.1155\/2012\/313961.","journal-title":"J Nanomater"},{"issue":"6","key":"894_CR35","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.eurpolymj.2013.03.001","volume":"49","author":"B Gyarmati","year":"2013","unstructured":"Gyarmati B, N\u00e9methy \u00c1, Szil\u00e1gyi A. Reversible disulphide formation in polymer networks: a versatile functional group from synthesis to applications. Eur Polymer J. 2013;49(6):1268\u201386. https:\/\/doi.org\/10.1016\/j.eurpolymj.2013.03.001.","journal-title":"Eur Polymer J"},{"key":"894_CR36","doi-asserted-by":"publisher","unstructured":"Prabahar K, Udhumansha U, Qushawy M. Optimization of Thiolated Chitosan Nanoparticles for the Enhancement of in Vivo Hypoglycemic Efficacy of Sitagliptin in Streptozotocin-Induced Diabetic Rats. Pharmaceutics. 2020;12(4). https:\/\/doi.org\/10.3390\/pharmaceutics12040300.","DOI":"10.3390\/pharmaceutics12040300"},{"key":"894_CR37","unstructured":"D.J. Mukherjee SB, V.Madhavan. Bilayered Mucoadhesive delivery system for extended release of Bisphosphonates. J Pharma Bio Sci. 2012;3(2):10."},{"issue":"10","key":"894_CR38","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1021\/acsanm.9b01377","volume":"2","author":"A Sood","year":"2019","unstructured":"Sood A, Dev A, Mohanbhai SJ, Shrimali N, Kapasiya M, Kushwaha AC, et al. Disulfide-bridged chitosan-Eudragit S-100 nanoparticles for colorectal cancer. ACS Appl Nano Mater. 2019;2(10):6409\u201317. https:\/\/doi.org\/10.1021\/acsanm.9b01377.","journal-title":"ACS Appl Nano Mater"},{"key":"894_CR39","doi-asserted-by":"publisher","first-page":"111118","DOI":"10.1016\/j.msec.2020.111118","volume":"115","author":"LSL Janardhanam","year":"2020","unstructured":"Janardhanam LSL, Indukuri VV, Verma P, Dusane AC, Venuganti VVK. Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer. Mater Sci Eng, C. 2020;115:111118. https:\/\/doi.org\/10.1016\/j.msec.2020.111118.","journal-title":"Mater Sci Eng, C"},{"key":"894_CR40","doi-asserted-by":"publisher","first-page":"119436","DOI":"10.1016\/j.ijpharm.2020.119436","volume":"584","author":"M Tiboni","year":"2020","unstructured":"Tiboni M, Benedetti S, Skouras A, Curzi G, Perinelli DR, Palmieri GF, et al. 3D-printed microfluidic chip for the preparation of glycyrrhetinic acid-loaded ethanolic liposomes. Int J Pharm. 2020;584:119436. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119436.","journal-title":"Int J Pharm"},{"key":"894_CR41","doi-asserted-by":"crossref","unstructured":"Cheng M, Gao X, Wang Y, Chen H, He B, Xu H, et al. Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo. 2013;11(9):3517\u201336.","DOI":"10.3390\/md11093517"},{"issue":"3","key":"894_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1208\/s12249-020-1618-2","volume":"21","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, Swarnakar NK, Mohamed DF, Attia MA, Pauletti GM. Permeation-enhancing nanoparticle formulation to enable oral absorption of enoxaparin. AAPS PharmSciTech. 2020;21(3):88. https:\/\/doi.org\/10.1208\/s12249-020-1618-2.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"894_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1208\/s12249-020-01655-7","volume":"21","author":"X Nie","year":"2020","unstructured":"Nie X, Liu Y, Li M, Yu X, Yuan W, Huang S, et al. SP94 Peptide-Functionalized PEG-PLGA nanoparticle loading with cryptotanshinone for targeting therapy of hepatocellular carcinoma. AAPS PharmSciTech. 2020;21(4):124. https:\/\/doi.org\/10.1208\/s12249-020-01655-7.","journal-title":"AAPS PharmSciTech"},{"key":"894_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jddst.2018.06.008","volume":"46","author":"D Mukherjee","year":"2018","unstructured":"Mukherjee D, Azamthulla M, Santhosh S, Dath G, Ghosh A, Natholia R, et al. Development and characterization of chitosan-based hydrogels as wound dressing materials. J Drug Deliv Sci Technol. 2018;46:498\u2013510. https:\/\/doi.org\/10.1016\/j.jddst.2018.06.008.","journal-title":"J Drug Deliv Sci Technol"},{"key":"894_CR45","doi-asserted-by":"publisher","first-page":"110253","DOI":"10.1016\/j.micromeso.2020.110253","volume":"303","author":"H \u00c7ift\u00e7i","year":"2020","unstructured":"\u00c7ift\u00e7i H, Arpa MD, G\u00fcla\u00e7ar \u0130M, \u00d6zcan L, Ersoy B. Development and evaluation of mesoporous montmorillonite\/magnetite nanocomposites loaded with 5-Fluorouracil. Microporous Mesoporous Mater. 2020;303:110253. https:\/\/doi.org\/10.1016\/j.micromeso.2020.110253.","journal-title":"Microporous Mesoporous Mater"},{"key":"894_CR46","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ijbiomac.2019.12.007","volume":"155","author":"S Javanbakht","year":"2020","unstructured":"Javanbakht S, Hemmati A, Namazi H, Heydari A. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery. Int J Biol Macromol. 2020;155:876\u201382. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.12.007.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"894_CR47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ijpharm.2013.06.030","volume":"453","author":"M Rajan","year":"2013","unstructured":"Rajan M, Raj V, Al-Arfaj AA, Murugan AM. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles. Int J Pharm. 2013;453(2):514\u201322. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.030.","journal-title":"Int J Pharm"},{"key":"894_CR48","doi-asserted-by":"publisher","unstructured":"Guerrini L, Alvarez-Puebla RA, Pazos-Perez N. Surface Modifications of Nanoparticles for Stability in Biological Fluids. Materials (Basel, Switzerland). 2018;11(7). https:\/\/doi.org\/10.3390\/ma11071154.","DOI":"10.3390\/ma11071154"},{"key":"894_CR49","doi-asserted-by":"publisher","unstructured":"Kadry MO, Abdel-Megeed RM, El-Meliegy E, Abdel-Hamid A-HZ. Crosstalk between GSK-3, c-Fos, NF\u03baB and TNF-\u03b1 signaling pathways play an ambitious role in Chitosan Nanoparticles Cancer Therapy. Toxicol Rep. 2018;5:723\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.toxrep.2018.06.002","DOI":"10.1016\/j.toxrep.2018.06.002"},{"issue":"3","key":"894_CR50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.5b00677","volume":"13","author":"Y Cai","year":"2016","unstructured":"Cai Y, Xu Y, Chan HF, Fang X, He C, Chen M. Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy. Mol Pharm. 2016;13(3):699\u2013709. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00677.","journal-title":"Mol Pharm"},{"issue":"7","key":"894_CR51","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","volume":"16","author":"C Nadolny","year":"2015","unstructured":"Nadolny C, Dong X. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer. Cancer Biol Ther. 2015;16(7):997\u20131004. https:\/\/doi.org\/10.1080\/15384047.2015.1045693.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"894_CR52","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/s1097-2765(03)00236-3","volume":"11","author":"EP Sablin","year":"2003","unstructured":"Sablin EP, Krylova IN, Fletterick RJ, Ingraham HA. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell. 2003;11(6):1575\u201385. https:\/\/doi.org\/10.1016\/s1097-2765(03)00236-3.","journal-title":"Mol Cell"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00894-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00894-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00894-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T14:46:43Z","timestamp":1630939603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00894-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00894-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"26 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed for animal studies were in compliance with the guidelines of the ethical committee of the Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences with regard to the care and use of laboratory animals. The experimental protocol was approved by Institutional Animal Ethical Committee with the approval number XVIII\/MSRFPH\/M-06\/0.8.02.2017.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No human studies were carried out by the authors for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The protocol of the experimental design was approved by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India, and by the Institutional Animal Ethics Committee (Registration No: 220\/PO\/ReBi\/S\/2000\/CPCSEA\/02.05.2016).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}